You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Claims for Patent: 6,143,524


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,143,524
Title: Peptide and protein fusions to thioredoxin, thioredoxin-like molecules, and modified thioredoxin-like molecules
Abstract:Provided is a fusion molecule comprising a DNA sequence encoding a thioredoxin-like protein fused to a DNA sequence encoding a second peptide or protein. The peptide or protein may be fused to the amino terminus of the thioredoxin-like molecule, the carboxyl terminus of the thioredoxin-like molecule, or within the thioredoxin-like molecule, for example at the active-site loop of the molecule. The fusion molecule may be modified to introduce one or more metal-binding/chelating amino-acid residues to aid in purification. Expression of this fusion molecule under the control of a regulatory sequence capable of directing its expression in a desired host cell, produces high levels of stable and soluble fusion protein. The fusion protein, located in the bacterial cytoplasm, may be selectively released from the cell by osmotic shock or freeze/thaw procedures. It may be optionally cleaved to liberate the soluble, correctly folded heterologous protein from the thioredoxin-like portion.
Inventor(s): McCoy; John (Reading, MA), DiBlasio-Smith; Elizabeth (Tyngsboro, MA), Grant; Kathleen (Salem, MA), LaVallie; Edward R. (Tewksbury, MA)
Assignee: Genetics Institute, Inc. (Cambridge, MA)
Application Number:08/810,436
Patent Claims:1. An isolated DNA molecule comprising a DNA sequence selected from the group consisting of:

(a) nucleotides 2599 through 3132 of SEQ ID NO:13, and

(b) nucleotides encoding amino acids 120 through 296 of SEQ ID NO:14.

2. A nucleic acid vector comprising a DNA according to claim 1.

3. A host cell transformed or transfected with a nucleic acid vector of claim 1.

4. A method for producing IL-11 polypeptide comprising:

(a) growing, in culture, a host cell of claim 3, and

(b) isolating from said host cell or said culture the polypeptide product of the expression of said DNA.

5. A purified interleukin-11 (IL-11) protein encoded by a DNA encoding amino acids 120 through 296 of SEQ ID NO:14.

6. A purified IL-11 protien amino acids 120 through 296 of SEQ ID NO:13.

7. A composition comprising an IL-11 protein encoded by a DNA molecule comprising a DNA sequence selected from the group consisting of:

(a) nucleotides 2599 through 3132 of SEQ ID NO:13, and

(b) nucleotides encoding amino acids 120 through 296 of SEQ ID NO:14.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.